We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RTN
126
DELISTED
Raytheon Company
RTN
$29.3M 0.18%
168,338
-180,095
-52% -$32.4M
BRKR icon
127
Bruker
BRKR
$7.8B
$28.8M 0.18%
577,123
-244,557
-30% -$10.3M
HLT icon
128
Hilton Worldwide
HLT
$72.5B
$28.7M 0.18%
+293,861
New +$26.7M
TROW icon
129
T. Rowe Price
TROW
$24.2B
$27.9M 0.17%
253,908
+223,115
+725% +$23.5M
TM icon
130
Toyota
TM
$222B
$27.8M 0.17%
224,212
+219,760
+4,936% +$26.8M
ANSS
131
DELISTED
Ansys
ANSS
$27.4M 0.17%
133,884
+31,370
+31% +$5.98M
PBR icon
132
Petrobras
PBR
$119B
$27.1M 0.17%
1,742,823
+933,108
+115% +$14.2M
KLAC icon
133
KLA
KLAC
$252B
$27M 0.17%
2,285,600
+453,720
+25% +$5.25M
AVGO icon
134
Broadcom
AVGO
$2T
$25.7M 0.16%
893,460
-661,980
-43% -$19.3M
HPQ icon
135
HP
HPQ
$25.8B
$25.4M 0.16%
1,223,850
+319,246
+35% +$6.31M
AXTA icon
136
Axalta
AXTA
$8.03B
$24.8M 0.15%
833,282
+74,570
+10% +$1.98M
MCO icon
137
Moody's
MCO
$81.9B
$24.7M 0.15%
126,596
+39,359
+45% +$7.47M
MRO
138
DELISTED
Marathon Oil Corporation
MRO
$24.6M 0.15%
1,734,054
-1,926,582
-53% -$29.8M
SAGE
139
DELISTED
Sage Therapeutics
SAGE
$23.1M 0.14%
126,217
-414,191
-77% -$70.7M
ARGX icon
140
argenx
ARGX
$54.8B
$22.9M 0.14%
161,638
-60,289
-27% -$7.65M
TWNK
141
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$21.8M 0.14%
1,507,725
+1,241,305
+466% +$16.6M
IEX icon
142
IDEX
IEX
$17.2B
$21.6M 0.13%
+125,715
New +$19.7M
TSM icon
143
TSMC
TSM
$2.17T
$21.4M 0.13%
546,593
+537,093
+5,654% +$22.1M
ERIC icon
144
Ericsson
ERIC
$33.3B
$21.1M 0.13%
+2,220,102
New +$21.5M
BJRI icon
145
BJ's Restaurants
BJRI
$1.49B
$20.9M 0.13%
475,590
+321,809
+209% +$14.7M
BFAM icon
146
Bright Horizons
BFAM
$3.89B
$20.7M 0.13%
137,250
+136,950
+45,650% +$18.4M
KMPR icon
147
Kemper
KMPR
$1.76B
$20.6M 0.13%
+239,137
New +$20.4M
FMC icon
148
FMC
FMC
$1.32B
$20.6M 0.13%
248,582
+64,721
+35% +$5.08M
WMB icon
149
Williams Companies
WMB
$87.8B
$20.6M 0.13%
735,023
+628,691
+591% +$17.5M
MDLZ icon
150
Mondelez International
MDLZ
$80.1B
$20.4M 0.13%
+379,059
New +$19.7M
4 5
6
7 8

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.